Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agents for Ocular Vascular Diseases: Clinical Practice Guideline

PURPOSE: To provide the clinical recommendations for the administration of intravitreal anti-vascular endothelial growth factor (VEGF) drugs especially bavacizumab for ocular vascular diseases including diabetic macular edema, neovascular age-related macular degeneration, myopic choroidal neovascula...

Descripción completa

Detalles Bibliográficos
Autores principales: Nikkhah, Homayoun, Karimi, Saeed, Ahmadieh, Hamid, Azarmina, Mohsen, Abrishami, Majid, Ahoor, Hossein, Alizadeh, Yousef, Behboudi, Hasan, Daftarian, Narsis, Dehghan, Mohammad Hossein, Entezari, Morteza, Farrahi, Fereydoun, Ghanbari, Heshmatollah, Falavarjani, Khalil Ghasemi, Javadi, Mohammad Ali, Karkhaneh, Reza, Moradian, Siamak, Manaviat, Masoud Reza, Mehryar, Morsal, Nourinia, Ramin, Parvaresh, Mohammad Mehdi, Ramezani, Alireza, Haghi, Alireza Ragati, Riazi-Esfahani, Mohammad, Soheilian, Masoud, Shahsavari, Mohsen, Shahriari, Hossein-Ali, Rajavi, Zhale, Safi, Sare, Shirvani, Armin, Rahmani, Saeed, Sabbaghi, Hamideh, Pakbin, Mojgan, Kheiri, Bahareh, Ziaei, Hossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Clinical Practice Guideline
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5905310/
https://www.ncbi.nlm.nih.gov/pubmed/29719645
http://dx.doi.org/10.4103/jovr.jovr_50_18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5905310/
https://www.ncbi.nlm.nih.gov/pubmed/29719645
http://dx.doi.org/10.4103/jovr.jovr_50_18

Ejemplares similares